Status:
COMPLETED
Assessing Free Immunoglobulin Light Chains in Patients With Myeloma
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
Multiple myeloma is a disorder in which malignant plasma cells accumulate in the bone marrow. These plasma cells produce an abnormal protein called paraprotein / M spike in the serum which can be seri...
Eligibility Criteria
Inclusion
- Multiple Myeloma patients in CR
Exclusion
- not being able to give consent
Key Trial Info
Start Date :
June 1 2002
Trial Type :
OBSERVATIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00301275
Start Date
June 1 2002
End Date
December 1 2005
Last Update
March 10 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS trust
Sutton, Surrey, United Kingdom, SM2 5PT